Fig. 1. Upregulated SNHG3 was closely correlated with poor prognosis for breast cancer patients. (A) The expression of SNHG3 in 42 paired breast cancer tissues and matched adjacent normal tissues was detected using qRT-PCR. (B) The expression of SNHG3 in different advanced pathological stages N0, N1, N2 and N3. (C) The expression of SNHG3 in 31 breast cancer patients with distant metastasis and 11 breast cancer patients with no distant metastasis. (D) Kaplan–Meier curves and a log-rank test of overall survival for all breast cancer patients. *P < 0.05, **P < 0.01, and ***P < 0.001.